Melinda Lackey

2023

In 2023, Melinda Lackey earned a total compensation of $701.7K as SVP, Legal & Administration at ZIOPHARM Oncology, a 8% decrease compared to previous year.

Compensation breakdown

Option Awards$76,620
Salary$312,084
Other$313,033
Total$701,737

Lackey received $313K in other compensation, accounting for 45% of the total pay in 2023.

Lackey also received $76.6K in option awards and $312.1K in salary.

Rankings

In 2023, Melinda Lackey's compensation ranked 1,626th out of 3,006 executives tracked by ExecPay. In other words, Lackey earned more than 45.9% of executives.

ClassificationRankingPercentile
All
1,626
out of 3,006
46th
Division
Manufacturing
954
out of 1,650
42nd
Major group
Chemicals And Allied Products
613
out of 918
33rd
Industry group
Drugs
597
out of 881
32nd
Industry
Pharmaceutical Preparations
424
out of 637
33rd
Source: SEC filing on April 26, 2024.

Lackey's colleagues

We found two more compensation records of executives who worked with Melinda Lackey at ZIOPHARM Oncology in 2023.

2023

Kevin Boyle

ZIOPHARM Oncology

Chief Executive Officer

2023

Drew Deniger

ZIOPHARM Oncology

VP, Research and Development

News

You may also like